Literature DB >> 19193985

C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects.

I Goracy1, L Cyryłowski, M Kaczmarczyk, A Fabian, D Koziarska, J Goracy, A Ciechanowicz.   

Abstract

Hyperhomocysteinemia is reported to be an independent risk factor for the development of ischemic stroke. Several studies on genetic variants of methylenetetrahydrofolate reductase (MTHFR, which plays a crucial role in regulation of plasma homocysteine concentration) reported an association between C677T gene polymorphism and stroke in some Asian populations. No study but one detected this association in Caucasians. The purpose of the present case-control study was to find a relationship between MTHFR genotypes and stroke in a Polish population. MTHFR genotypes were determined by PCR in 152 patients with ischemic stroke from northwestern Poland and in 135 consecutive newborns from the same population. The TT genotype and the T allele were significantly more frequent in patients than in the control group (11.8% vs. 4.4%, and 34.5% vs. 21.5%, P<0.01). When males and females were analyzed separately, the differences were statistically significant in both genders. It is concluded that presence of the T allele is a risk factor for ischemic stroke in Polish subjects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193985     DOI: 10.1007/BF03195654

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  28 in total

1.  Exon 1 polymorphism of the B2BKR gene does not influence the clinical status of patients with hereditary angioedema.

Authors:  Tomás Freiberger; Martina Vyskocilová; Lenka Kolárová; Pavel Kuklínek; Olga Krystůfková; Marie Lahodná; Jana Hanzlíková; Jirí Litzman
Journal:  Hum Immunol       Date:  2002-06       Impact factor: 2.850

2.  Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke.

Authors:  B Kristensen; J Malm; T K Nilsson; J Hultdin; B Carlberg; G Dahlén; T Olsson
Journal:  Stroke       Date:  1999-05       Impact factor: 7.914

3.  Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease.

Authors:  H Morita; J Taguchi; H Kurihara; M Kitaoka; H Kaneda; Y Kurihara; K Maemura; T Shindo; T Minamino; M Ohno; K Yamaoki; K Ogasawara; T Aizawa; S Suzuki; Y Yazaki
Journal:  Circulation       Date:  1997-04-15       Impact factor: 29.690

4.  Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke.

Authors:  Z Szolnoki; V Havasi; J Bene; K Komlósi; D Szöke; F Somogyvári; A Kondacs; M Szabó; L Fodor; A Bodor; I Gáti; I Wittman; B Melegh
Journal:  Acta Neurol Scand       Date:  2005-01       Impact factor: 3.209

5.  Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.

Authors:  J W Eikelboom; G J Hankey; S S Anand; E Lofthouse; N Staples; R I Baker
Journal:  Stroke       Date:  2000-05       Impact factor: 7.914

6.  Common genetic variants of homocysteine metabolism in ischemic stroke: a case-control study.

Authors:  M Linnebank; M Montenarh; H Kölsch; A Linnebank; K Schnez; D Schweichel; C Pohl; H Urbach; R Heun; U Harbrecht; T Klockgether; U Wüllner
Journal:  Eur J Neurol       Date:  2005-08       Impact factor: 6.089

7.  Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke.

Authors:  Alessandro Pezzini; Elisabetta Del Zotto; Silvana Archetti; Riccardo Negrini; Paolo Bani; Alberto Albertini; Mario Grassi; Deodato Assanelli; Roberto Gasparotti; Luigi Amedeo Vignolo; Mauro Magoni; Alessandro Padovani
Journal:  Stroke       Date:  2002-03       Impact factor: 7.914

8.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

9.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

10.  No association of endometriosis with glutathione S-transferase M1 and T1 null mutations in a Japanese population.

Authors:  Mayumi Morizane; Shigeki Yoshida; Satoshi Nakago; Shinya Hamana; Takeshi Maruo; Stephen Kennedy
Journal:  J Soc Gynecol Investig       Date:  2004-02
View more
  3 in total

1.  Methylenetetrahydrofolate reductase C677T gene polymorphism and colorectal cancer risk: A case-control study.

Authors:  Guancheng Yin; Hanxin Ming; Xiao Zheng; Yi Xuan; Jianwei Liang; Xing Jin
Journal:  Oncol Lett       Date:  2012-05-30       Impact factor: 2.967

2.  Synergistic effect of MTHFR C677T and F2 G20210A polymorphisms on ischemic stroke.

Authors:  Thierry Paluku They-They; Omar Battas; Sellama Nadifi
Journal:  Neurosci Bull       Date:  2013-10-16       Impact factor: 5.203

3.  A prospective cohort study of MTHFR C677T gene polymorphism and its influence on the therapeutic effect of homocysteine in stroke patients with hyperhomocysteinemia.

Authors:  Xiaoxia Du; Lin Xiao; Rong Sun; Kunpeng Li; Lin Liang; Luping Song; Zhizhong Liu
Journal:  BMC Neurol       Date:  2020-04-11       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.